Can serum (CRP) levels estimate the outome of talc pleurodesis in malignant pleural effusions? Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003
Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010
The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017
Is it important to determine pleural fluid amylase in patients with malignant pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007
Pleural NT-PROBNP and albumin gradient (serum-pleural levels difference) in patients with exudative pleural effusion (PE) and previous diuretic therapy Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009
Predictors of trapped lung in patients with malignant pleural effusions; comparison of pleural elastance and pleural fluid pH Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Pleural fluid procalcitonin levels in identifying pleural effusions due to infection Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Utility of pleural fluid glucose measurement in TB pleural effusions. Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020
Role of serum and pleural fluid NT-proBNP levels in identifying pleural effusion due to heart failure Source: Annual Congress 2008 - Pleural effusion Year: 2008
The profile of neutrophils and D-dimer in pleural fluid is useful to monitor the pleurodesis process after talc poudrage in malignant pleural effusions (MPE) Source: Eur Respir J 2002; 20: Suppl. 38, 70s Year: 2002
Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012
Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004
Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010